These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 9691085)
21. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats. Mansoori A; Oryan S; Nematbakhsh M J Physiol Pharmacol; 2014 Oct; 65(5):633-9. PubMed ID: 25371522 [TBL] [Abstract][Full Text] [Related]
23. Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Yoneda M; Sanada H; Yatabe J; Midorikawa S; Hashimoto S; Sasaki M; Katoh T; Watanabe T; Andrews PM; Jose PA; Felder RA Hypertension; 2005 Jul; 46(1):58-65. PubMed ID: 15956107 [TBL] [Abstract][Full Text] [Related]
24. Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide. O'Tierney PF; Komolova M; Tse MY; Adams MA; Pang SC J Hypertens; 2008 Feb; 26(2):303-11. PubMed ID: 18192845 [TBL] [Abstract][Full Text] [Related]
25. Substitution of connexin40 with connexin45 prevents hyperreninemia and attenuates hypertension. Schweda F; Kurtz L; de Wit C; Janssen-Bienhold U; Kurtz A; Wagner C Kidney Int; 2009 Mar; 75(5):482-9. PubMed ID: 19109587 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Felder RA; Jose PA Nat Clin Pract Nephrol; 2006 Nov; 2(11):637-50. PubMed ID: 17066056 [TBL] [Abstract][Full Text] [Related]
27. [Hypertensive syndrome in kidney diseases]. Tareeva IE; Kutyrina IM Klin Med (Mosk); 1985 Apr; 63(4):6-12. PubMed ID: 3897700 [No Abstract] [Full Text] [Related]
28. The effect on total renal and tubular function and plasma renin of a moderate isotonic saline load in rats anesthetized with amytal and inactin. Leyssac PP; Frederiksen O; Skinner SL Acta Physiol Scand; 1975 Aug; 94(4):472-83. PubMed ID: 1180088 [TBL] [Abstract][Full Text] [Related]
29. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841 [TBL] [Abstract][Full Text] [Related]
30. [Pathophysiology of the renin-angiotensin system]. Klett C; Hellmann W; Hackenthal E; Ganten D Wien Med Wochenschr; 1990 Jan; 140(1-2):2-12. PubMed ID: 2106755 [TBL] [Abstract][Full Text] [Related]
31. A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice. Jackson KL; Marques FZ; Watson AM; Palma-Rigo K; Nguyen-Huu TP; Morris BJ; Charchar FJ; Davern PJ; Head GA Hypertension; 2013 Oct; 62(4):775-81. PubMed ID: 23897069 [TBL] [Abstract][Full Text] [Related]
34. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Laragh JH; Sealey JE Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070 [TBL] [Abstract][Full Text] [Related]
35. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension. Inada Y; Murakami M; Kaido K; Nakao K Arzneimittelforschung; 1999 Jan; 49(1):13-21. PubMed ID: 10028373 [TBL] [Abstract][Full Text] [Related]
36. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696 [TBL] [Abstract][Full Text] [Related]
37. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation. Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice. Wang X; Escano CS; Asico L; Jones JE; Barte A; Lau YS; Jose PA; Armando I Hypertension; 2013 Aug; 62(2):295-301. PubMed ID: 23753418 [TBL] [Abstract][Full Text] [Related]
39. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Ueda A; Ozono R; Oshima T; Yano A; Kambe M; Teranishi Y; Katsuki M; Chayama K Am J Hypertens; 2003 Oct; 16(10):853-8. PubMed ID: 14553965 [TBL] [Abstract][Full Text] [Related]
40. What we can learn from the selective manipulation of dopaminergic receptors about the pathogenesis and treatment of hypertension? Jose PA; Felder RA Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):447-51. PubMed ID: 8937815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]